Valuation RaySearch Laboratories AB
Stocks
RAY B
SE0000135485
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 197.00 SEK | +1.39% |
|
+6.31% | -13.60% |
Company Valuation: RaySearch Laboratories AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,937 | 2,331 | 3,096 | 7,405 | 7,816 | 6,623 | - | - |
| Change | - | 20.35% | 32.79% | 139.2% | 5.56% | -15.27% | - | - |
| Enterprise Value (EV) 1 | 2,397 | 2,727 | 3,281 | 7,414 | 7,804 | 6,789 | 6,656 | 6,459 |
| Change | - | 13.78% | 20.33% | 125.95% | 5.26% | -13.01% | -1.96% | -2.96% |
| P/E | -40.9x | 98.6x | 37.9x | 36.4x | 34.3x | 25.2x | 20.3x | 17.7x |
| PBR | 2.98x | 3.55x | 4.21x | 8.45x | 7.93x | 7.64x | 6.4x | 5.27x |
| PEG | - | -1x | 0x | 0x | 2.9x | 1.5x | 0.8x | 1.2x |
| Capitalization / Revenue | 3.02x | 2.76x | 3.03x | 6.21x | 5.81x | 4.79x | 4.1x | 3.62x |
| EV / Revenue | 3.74x | 3.23x | 3.21x | 6.22x | 5.81x | 4.91x | 4.12x | 3.54x |
| EV / EBITDA | 12.2x | 8.03x | 8.2x | 13.3x | 13.4x | 10.8x | 9.09x | 7.59x |
| EV / EBIT | -44.8x | 63.9x | 28.6x | 28.5x | 26.7x | 19.7x | 15.7x | 12.2x |
| EV / FCF | 234x | - | - | - | 21.7x | 38.8x | 24.6x | 18.6x |
| FCF Yield | 0.43% | - | - | - | 4.6% | 2.58% | 4.07% | 5.39% |
| Dividend per Share 2 | - | - | 0.7 | 3 | 3 | 4 | 4.5 | 5.55 |
| Rate of return | - | - | 0.78% | 1.39% | 1.32% | 2.03% | 2.28% | 2.82% |
| EPS 2 | -1.38 | 0.69 | 2.38 | 5.94 | 6.65 | 7.805 | 9.7 | 11.1 |
| Distribution rate | - | - | 29.4% | 50.5% | 45.1% | 51.2% | 46.4% | 50% |
| Net sales 1 | 641.1 | 843.6 | 1,022 | 1,192 | 1,344 | 1,382 | 1,614 | 1,827 |
| EBITDA 1 | 196.7 | 339.7 | 400.1 | 558 | 583.5 | 631.5 | 732.5 | 850.5 |
| EBIT 1 | -53.5 | 42.7 | 114.9 | 260.5 | 292.3 | 344.5 | 423.5 | 530 |
| Net income 1 | -47.3 | 23.8 | 81.57 | 203.5 | 227.8 | 265.5 | 328 | 412 |
| Net Debt 1 | 459.7 | 395.9 | 185.7 | 9.2 | -12.5 | 166 | 33 | -164 |
| Reference price 2 | 56.50 | 68.00 | 90.30 | 216.00 | 228.00 | 197.00 | 197.00 | 197.00 |
| Nbr of stocks (in thousands) | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | 33,618 | - | - |
| Announcement Date | 2/23/22 | 2/28/23 | 2/23/24 | 2/21/25 | 2/12/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 24.89x | 4.84x | 10.61x | 2.06% | 655M | ||
| 34.61x | 6.04x | 23.12x | 0.27% | 258B | ||
| 39.39x | 6.96x | 22.02x | 0.62% | 163B | ||
| 45.71x | 12.3x | 27.14x | -.--% | 151B | ||
| 16.59x | 3.33x | 10.84x | -.--% | 63.97B | ||
| 35.43x | 6.97x | 22.13x | -.--% | 50.78B | ||
| 20.05x | 2.41x | 12.18x | 2.52% | 50.94B | ||
| 34.21x | 6.76x | 22.95x | 0.59% | 49.49B | ||
| 47.93x | 11.82x | 26.06x | -.--% | 50.68B | ||
| 77.76x | 7.4x | 22.54x | -.--% | 43.64B | ||
| Average | 37.66x | 6.88x | 19.96x | 0.61% | 88.16B | |
| Weighted average by Cap. | 38.17x | 7.37x | 22.15x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RAY B Stock
- Valuation RaySearch Laboratories AB
Select your edition
All financial news and data tailored to specific country editions
















